Document is current

Any future updates will be listed below

Reducing toxicity and enhancing efficacy of doxorubicin by liposomal doxorubicin and aprepitant in breast cancer

Crossref DOI link: https://doi.org/10.1038/s41598-025-94291-9

Published Online: 2025-03-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark